0% found this document useful (0 votes)
109 views32 pages

Types and Management of Anemia Disorders

This document discusses different types of anemias including normocytic, hypochromic, macrocytic, and hemolytic anemias. It provides details on the causes, signs and symptoms, diagnostic testing, and treatment for various specific anemias such as iron deficiency anemia, sickle cell anemia, glucose-6-phosphate dehydrogenase deficiency, thalassemia, and pernicious anemia. Classification of anemias includes consideration of red blood cell size, shape, and hemoglobin content. Management involves treating underlying causes and compensating for deficient components.
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
109 views32 pages

Types and Management of Anemia Disorders

This document discusses different types of anemias including normocytic, hypochromic, macrocytic, and hemolytic anemias. It provides details on the causes, signs and symptoms, diagnostic testing, and treatment for various specific anemias such as iron deficiency anemia, sickle cell anemia, glucose-6-phosphate dehydrogenase deficiency, thalassemia, and pernicious anemia. Classification of anemias includes consideration of red blood cell size, shape, and hemoglobin content. Management involves treating underlying causes and compensating for deficient components.
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

Anemias

DISORDERS OF THE RED BLOOD


CELLS
ANEMIA

 A reduction in the quantity of the oxygen-


carrying pigment .Hemoglobin in the blood
 Classification
1. Macrocytic anemias
2. Hypochromic
3. Microcytic anemias
4. Normocytic anemias
5. Hemolytic anemia
Normocytic Anemia

 Marked by impaired production of


erythrocytes by the bone marrow or
by abnormal or uncompensated loss
of circulating RBCs
 The remaining RBCs are normal in
color and size, but too few in numbers
Normocytic Anemia
1. Acute bld loss anemia
 Bld loss sufficient to cause anemia: internal
bleeding, nephritis, disorders of the placenta,
trauma to the cord
 S/Sx: Reticulocyte ct; Children- Shock,
tachypnea; NB- gasping respiration, sternal
retractions, cyanosis
 Therapeutic Mgt: control of bleeding, place on
supine position, keep warm and dry, blood
transfusion, blood expander (PNSS os LRS)
Normocytic Anemia

2. Anemia of acute infection/inflamation


 May lead to increased destruction
of erythrocytes; osteomyelitis,
ulcerative colitis, renal disease
 Therapeutic mgt: Treatment of
underlying condition
Normocytic Anemia
3. Anemia of renal disease
 Causes loss of function of kidney cells an
decrease in erythropoietin production

 Mgt: Administration of Recombinant Human


Erythropoietin, treatment of underlying cause
Normocytic Anemia
4. Anemia of Neoplastic diseas
 Malignant growths such as leukemia,
lymphosarcoma
 May have accompanying blood loss if platelet
formation is decreased
 Mgt: remission of neoplastic process, blood
transfusion
Normocytic Anemia
5. Aplastic anemia
 Result from depression of hematopoiesis in the
bone marrow, formation and development of bld
cells are affected. Occurs bet. 6-8 mos
 May be (1) Congenital(Fanconie’s syndrome)
 Autosomal recessive trait, child is born with number
of congenital anomalies( skeletal, renal anomalies;
hypogenitalism, short stature), between 4-12 y/o
child begin to mannifest symptoms of
PANCYTOPENIA
Normocytic Anemia
 (2) Acquired- excessive exposure to radiation, drugs,
chemicals that damage the bone marrow.
 Drugs: chloramphenicol, sulfonamides, arsenic,
hydantoin, benzene, quinine, chomotherapeutic
agents

 S/Sx: Pale, easy fatigability, anorexia, petechiae, prone


to infection, cardiac decompensation,
Normocytic Anemia

 APLASTIC ANEMIA
 Therapeutic mgt: BMT,
administration of Antithymocyte
globulin(ATG), cyclosporin;
testosterone- for RBC growth, BT
Normocytic Anemia

6. Hypoplastic anemia
 Results from depression of hematopoietic activity,
on;y RBCs are affected
 Types: (1) congenital (Blackfan-Diamond
syndrome)
 Tx: Long term transfusion of PRBC- causes
HEMOSIDEROSIS- treated with
HYPODERMOCLYSIS- SQ infusion of deforaxamine
(Desferal), binds with iron and aids excretion in urine
Hypoplastic anemia

 (2) Acquiredreduction of RBC is transient so


no therapy is needed
 Increases erythropoiesis with
corticosteroid therapy
Normocytic Anemia

7. Hypersplenism
 Cells are filtered slowly therefore destroying cells
in the process
 Underlying spleenic condition causes the
syndrome
 Mgt: Spleenectomy, done after 2 years with
immunization against pneumococci an H.
Influenzae + penicillin
Hypochromic Anemia
 Results from inadequate hemoglobin
synthesis, erythrocytes appear
pale(hypochromia), reduced diameter
(microcytic), occurs bet. Ages 9 mos-3 yrs

1. Iron-deficiency anemia
 Most common anemia in infancy and chldhood
 Occur when intake of iron is inadequate,
preventing proper hemoglobin formation
Iron-deficiency anemia

 Causes: infants- born to iron deficient mother, GIT


structural defects(chalasia, pyloric stenosis);
children/>2yrs- GIT lesions, polyps, ulcarative
colitis
 Prevention: daily intake of 6-15 mg iron, iron
supplementation at about 2 mos of age
 S/Sx: pale mucous membrane, poor muscle tone,
decreased activity, possible enlarged heart/spleen,
spoon-shaped fingernails; fearful, less active, less
persistent( CNS maturation is affected)
Iron-deficiency anemia

 Therapeutic mgt: treatment of underlying


cause,iron-fortified formula for 1 yr, iron-rich
diet with extra vit. C
Macrocytic Anemia

 A.K.A. Megaloblastic anemia


 Caused by nutritionl deficiency, characterized by
abnormally large immature erythrocyte or
magaloblast
1. Anemia of Folic Acid deficiency
 Due to deficient folic acid and vit.C in diet
2. Pernicious Anemia (vit. B12 deficiency)
 Deficient or inability to use vit. B12, appars in teh
first 2 years of life
Pernicious Anemia

• S/Sx- pale, anorexic; irritable; smooth,


beefy-red tongue
• Mgt: Lifelong monhly intramuscular
injection of vit. B12
Hemolytic Anemia

 Anemia in which there is increased


destruction of erythrocyte may be caused by
abnormalities of erythrocyte structure or
extracellular destruction forces

1. Glucose-6-Phosphate Dehydrogenase Deficiency


 Lack of the enzyme results in premature
destruction of RBC if they are exposed to
antioxidant such as acetylsalicylic acid
GLUCOSE-6-PHOSPHATE
DEHYDROGENASE DEFICIENCY

• Transmitted as sex-linked recessive trait


• Occur frequently in african-american,
Asian, Sephardic jewish and
mediterranian descent
• Occurs in two identifiable forms
1. Nonspherocytic hemolytic anemia
• Hemolysis, jaundice,
spleenomegaly, aplastic crisis
GLUCOSE-6-PHOSPHATE
DEHYDROGENASE DEFICIENCY
2. Drug induced
• bld patterns are normal until exposed to ava
beans, anttipyretics, sulfonamides ,
antimalarials, acetylsalicylic acid(most
common)
• 2 days after ingestion of antioxidant, child
begins to show signs of hemolysis
• Blood smear- Heinz bodies( oddly shaped
RBC)
• Fever and back pain
• Self-limitting
GLUCOSE-6-PHOSPHATE
DEHYDROGENASE DEFICIENCY

• diagnosed by rapid enzyme screening


test or electrophoretic analysis of RBCs.

• Mgt: parent teaching regarding the


child’s metabolism
Sickle-cell Anemia

 The presence of elongated and crescent-


shaped (sickled) RBCs- when submitted to
low oxygen tension
 Autosomal recessive inherited disorder on
the beta chain of hemoglobin
 Fetal hemoglobin contains gamma not beta
chain-symptoms are not evident until child’s
hgb changes from fetal to adult form (6 mos)
Sickle-cell Anemia

 Can be diagnosed by chorionic villi sampling


or from cord bld during amniocentesis
 can be identified at birth by NBS
 Occurs almost exclusively among african-
american
 Sickle cell disease- homozygous
 Sickle cell trait- heterozygous
Sickle-cell Anemia

 Assessment: Hemoglobin electrophoresis-


use to diagnosed sickle-cell anemia
 S/Sx: fever; anemia, Pale, easy fatigability,
anorexia; hand-foot syndrome( swelling due
to infarction); protruding abdomen; (adult)
spleen atrophy due to repeated infarction and
atrophy- infection prone; chest syndrome
(similar to pneumonia); icteric sclerae;
decreased vision; priapism
Sickle-cell Anemia

 Sickle-cell crisis- a sudden, severe onset of


sickling which occur when child has an illness
causing dehydration and respiratory
infection leading to lowered O2 exchange
 Sx: fever, icteric sclerae, acute abdominal
pain(spleenomegally, hepatomegally)
Sickle-cell Anemia

 Therapeutic mgt: chld with SCC has 3 primary


needs: pain relief; adequate hydration;
oxygenation
 Hydroxyurea- antineoplastic agent, may increse
production of hemoglobin F
THALASsEMIAS

 Autosomal recessive trait associated with


abnormalities of the beta chain of the adult
Hemoglobin (HgbA). Occur mostly on
Mediterranean population, but may affect
African and Asian traits
Thalassemia Minor

 Heterozygous Beta-thalassemia
 Produces both normal and abnormal hgb, rbc
count will be normal but hemoglobin
concentration is decreased
 Cell are moderately hypochromic and microcytic
due to poor hgb formation
 Pt. Shows no symptom other than pallor and
requires no treatment, life expectancy is normal.
Thalassemia Major/Cooley’s
a=Anemia
 Homozygous Beta-thalassemia

 Beta-chain hgb defect therefore Sx appear aonly


after HgbF is replaced by HgbA after 6 mos of life
 poikilocyte and basophilic stippling, high serum
iron level are present
 S/Sx: Anemia: pallor, irritability, anorexia
Thalassemia Major/Cooley’s a=Anemia

Body organ/ system Effects of abnormal production


 Bone marrow  Overstimulation leads to
increased facial-mandibular
growth
 Skin  Bronze-colored from jaundice
and hemosiderosis
 Spleen  Spleenomegaly
 Liver and GB  Cirrhosis/ cholelithiasis
 Pancreas  Destuction of Islets of
Langerhan/DM
 Heart  Failure due to overload
Thalassemia Major/Cooley’s
a=Anemia
 Therapeutic Mgt: digitalis, diuretics, low-
sodium diet, BT of PRBC every 2-4 wks
( cosmetic facial alterationosteoporosis,
cardiac dilatation will be decreased),
Deferoxamine, spleenectomy to reduce rate
of hemolysis; Bone marrow stem
transplantation

You might also like